epirubicin has been researched along with Chronic Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Petit, T | 1 |
Boomsma, F; De Vries, EG; Gietema, JA; Haaksma, J; Meinardi, MT; Sleijfer, DT; Van Den Berg, MP; Van Der Graaf, WT; Van Veldhuisen, DJ | 1 |
Bisail, M; Cassisa, L; Casula, S; Fele, G; Malavasi, A; Manca, M | 1 |
1 review(s) available for epirubicin and Chronic Disease
Article | Year |
---|---|
[Anthracycline-induced cardiotoxicity].
Topics: Acute Disease; Anthracyclines; Arrhythmias, Cardiac; Biopsy; Chronic Disease; Creatine Kinase; Creatine Kinase, MB Form; Doxorubicin; Drug Synergism; Epirubicin; Humans; Isoenzymes; Liposomes; Myocardial Contraction; Myocardium | 2004 |
2 other study(ies) available for epirubicin and Chronic Disease
Article | Year |
---|---|
Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chronic Disease; Cross-Sectional Studies; Cyclophosphamide; Dyspnea; Epirubicin; Female; Fluorouracil; Heart Diseases; Humans; Long-Term Care; Middle Aged | 2002 |
[Discordance between clinical and immunological aspects in a case of chronic B-type lymphoproliferative syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chronic Disease; Cyclophosphamide; Epirubicin; Female; Humans; Leukemia, Prolymphocytic; Phenotype; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Stereoisomerism; Vincristine | 1991 |